MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Income Statement
NASDAQ:MREO - Nasdaq - US5894921072 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 10.00M | 0.00 | 50.14M | 0.00 | |||
| Cost Of Goods | 0.00 | 2.57M | -1.15M | 24.63M | N/A | |||
| Gross Profit | 0.00 | 7.43M | 1.15M | 25.52M | N/A | |||
| Operating Expenses | 47.36M | 35.84M | 54.83M | 54.30M | 48.17M | |||
| Research and Development | 20.93M | 17.42M | 30.75M | 32.40M | 20.96M | |||
| Selling, General, and Administrative Expenses | 26.43M | 18.42M | 24.08M | 21.91M | 27.21M | |||
| Operating Income | -47.36M | -28.42M | -53.68M | -28.79M | -48.17M | |||
| Interest Income/Expense | 2.46M | -2.85M | 8.82M | 48.55M | -151.10M | |||
| Other Income/Expense | 1.65M | 1.27M | 393.00K | -338.00K | -201.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -43.25M | -30.00M | -44.47M | 19.58M | -213.41M | |||
| Income Tax | 0.00 | -532.00K | -2.34M | 2.08M | -3.62M | |||
| Net Income | -43.25M | -29.47M | -42.13M | 17.50M | -209.80M | |||
| EBITDA | -46.28M | -27.36M | -52.78M | -27.91M | -46.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.29 | -0.19 | -0.34 | 0.15 | -3.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 74.26% | N/A | 50.89% | N/A | |||
| Profit Margin | N/A | -294.66% | N/A | 34.90% | N/A | |||
| Operating Profit Margin | N/A | -284.16% | N/A | -57.42% | N/A | |||
All data in USD